We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Eye drops target AMD.
- Authors
Dorey, Emma
- Abstract
The article focuses on the development of a topical eye drop for age-related macular degeneration (AMD) by OcuCure Therapeutics, an ophthalmic pharmaceutical company in Roanoke, Virginia. The active compound in the drops is a selective tubulin inhibitor, which both eliminates blood vessels and stops new ones forming by selectively inhibiting tubulin active in newly formed blood vessels. The company believes the drops could be used not only to treat wet AMD but also as prophylactic for dry AMD.
- Subjects
ROANOKE (Va.); VIRGINIA; DROPLETS; RETINAL degeneration; OCUCURE Therapeutics (Company); TUBULINS; BLOOD vessels
- Publication
Chemistry & Industry, 2006, Issue 22, p10
- ISSN
0009-3068
- Publication type
Article